 Broomfield, CO, Dec. 22, 2022 GLOBE NEWSWIRE via NewMediaWire Aclarion, Inc., Aclarion or the Company Nasdaq: ACON, ACONW, a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that Dr. Christopher Ames, Director of Spinal Deformity and Spine Tumor Surgery and Co-Director of the ... The post Dr. Christopher Ames to Join Aclarion as a Key Opini... 